Indian Immunologicals Ltd rolls out Havisure, India's first indigenous Hepatitis-A vaccine. The two-dose inactivated virus vaccine, developed over eight years, is priced at Rs 2,150 per dose. Extensive clinical trials have shown that Havisure is safe and efficacious for pediatric, adolescent, and adult use.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/IPjvkZr
Subscribe to:
Post Comments (Atom)
PM Surya Ghar Muft Bijli Yojana jobs boost! 1 lakh people to be trained to install solar panels in homes
PM Surya Ghar Muft Bijli Yojana: The ministries of renewable energy and skill development and entrepreneurship have collaboratively develope...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
-
Trading in stock markets this week will be majorly influenced by the upcoming quarterly earnings from IT majors TCS and Infosys, along with...
No comments:
Post a Comment